We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current PMN market cap is 25.5M. The company's latest EPS is USD -0.4042 and P/E is -14.84.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 113k | 0 | 132k | 31k | 236k |
| Operating Income | -2.41M | -3.87M | -3.55M | -2.68M | -7.69M |
| Net Income | -2.36M | -3.58M | -3.64M | -2.62M | 9.28M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1,000 | 2k | 0 | 0 | 0 |
| Operating Income | -7.36M | -5.68M | -8.29M | -23.38M | -14.26M |
| Net Income | -7.4M | -5.66M | -9.79M | -18.06M | -13.21M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 17.88M | 13.62M | 3.55M | 1.41M | 24.51M |
| Total Liabilities | 11.12M | 9.87M | 3.47M | 3.69M | 17.24M |
| Total Equity | 6.76M | 3.75M | 77k | -2.28M | 7.27M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.07M | 1.39M | 17.75M | 6.93M | 13.62M |
| Total Liabilities | 1.68M | 2.4M | 12.09M | 8.27M | 9.87M |
| Total Equity | 398k | -1.02M | 5.66M | -1.35M | 3.75M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.09M | -10.84M | -10.29M | -11.8M | -18.47M |
| Investing | N/A | -1,000 | N/A | N/A | N/A |
| Financing | 18.26M | 17.75M | 190k | 190k | 27.4M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.09M | -4.36M | -9.31M | -17.03M | -10.84M |
| Investing | N/A | -112k | 95k | -2k | -1,000 |
| Financing | 5.36M | 3.83M | 25.52M | 6.49M | 17.75M |
| Market Cap | 25.5M |
| Price to Earnings Ratio | -14.84 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 15.57 |
| Price to Book Ratio | 52.26 |
| Dividend Yield | - |
| Shares Outstanding | 32.69M |
| Average Volume (1 week) | 41.98k |
| Average Volume (1 Month) | 56.29k |
| 52 Week Change | -59.38% |
| 52 Week High | 2.61 |
| 52 Week Low | 0.6208 |
| Spread (Intraday) | 0.03 (3.81%) |
| Company Name | ProMIS Neurosciences Inc |
| Address |
suite 200 toronto, ontario M4S 3E2 |
| Website | https://www.promisneurosciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
